{"id":"NCT00305604","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)","officialTitle":"A Multicenter, Double-Blind, Randomized, Parallel Group Study to Evaluate the Safety and Efficacy of Sitagliptin in Elderly Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-03-08","primaryCompletion":"2008-03-12","completion":"2008-03-12","firstPosted":"2006-03-22","resultsPosted":"2009-05-01","lastUpdate":"2017-05-11"},"enrollment":206,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"sitagliptin phosphate","otherNames":["MK0431"]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the effect of treatment with sitagliptin compared to placebo in elderly patients with type 2 diabetes mellitus who have poor glycemic control with diet and exercise.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Hemoglobin A1c) at Week 24","timeFrame":"Baseline and Week 24","effectByArm":[{"arm":"Sitagliptin","deltaMin":-0.47,"sd":null},{"arm":"Placebo","deltaMin":0.23,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21428727"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7},"commonTop":["Any Infections and Infestations","Urinary Tract Infection"]}}